João L. Carapinha

Semaglutide NAION Risk: EMA Review Initiated Amid Conflicting Evidence
Advancing EU Health Technology Assessment: Insights from the HAG Meeting
National Health Survey 2024 Progress: Key Insights and Future Impacts
Pharmaceutical Data Collaboration Between Canada’s Drug Agency and CIHI
Thyroid Cancer Diagnosis: Delays During the Pandemic, Implications and Trends
GLP-1 Receptor Agonists: Balancing Benefits and Risks in Treatment Decisions